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A retrospective case review revealed an increase in sudden unexpected death (SUD) admittance 
at Salt River Mortuary (SRM) between 2014 and 2018, and that 40 % of SUD occurred in young 
individuals between the ages of 1 and 40 years old (SUDY). Despite extensive investigations, 
the cause of death remained undetermined in 26 % of SUDY cases. These dormant cases may 
benefit from retrospective post-mortem molecular autopsies for investigation into genetic 
causes of death. Often, formalin fixed paraffin embedded tissues (FFPETs) are the only archival 
sources of DNA available for retrospective analyses. This study aimed to optimise DNA 
recovery from FFPETs for potential use in molecular autopsies of unresolved SUDY cases. To 
this end, DNA was extracted from FFPET sections using the QIAamp® DNA FFPE tissue kit; 
the thickness and number of sections were varied. DNA was assessed using spectrophotometry, 
real-time PCR and digital capillary electrophoresis. Results showed that finer sectioning (1-µm 
thick as compared to 3-µm and 5-µm thick), improved DNA concentrations, purities and DNA 
fragment lengths. Increasing the number of 1-µm thick sections from 30 to 100, significantly 
improved DNA yield. DNA was not significantly more degraded for FFPETs stored for up to 
three years, which holds promise in the effectiveness of the technique for aged samples. The 
DNA extraction method developed in this study yielded a median of 320 ng (287 ng - 698 ng) 
of DNA with 55 % of DNA fragments being at least 400 bp in size. These results are especially 
informative for downstream molecular analyses, indicating that genotyping or sequencing 
assays need to be designed to target amplicons less than 400 bp in size. The degraded nature of 
the FFPET samples also suggests that massively parallel sequencing might be suited for 
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Chapter 1: Literature review 
1.1. INTRODUCTION 
1.1.1. Post-mortem investigations 
Sudden and unexpected death (SUD) is a devastating event and occurs when a seemingly 
healthy individual demises rapidly and without warning, and where cause of death is apparently 
unexplained. The unanticipated death occurs by non-violent means or is an instantaneous death 
within 24 hours of exhibiting any signs or symptoms of disease (World Health Organisation, 
2016).  
Previous studies have reported a temporal increase in SUD case admittance at two of the major 
mortuaries in South Africa, namely the Tygerberg medico-legal laboratory (TMLL) and Salt 
River mortuary (SRM) (Tiemensma, 2010; Mole, 2019). There was more than double the 
number of SUD cases admitted to TMLL in 2005 (7.5 %) than in 2001 (3.2 %) and 
approximately three times the number of SUD cases admitted to SRM in 2016 (19.2 %) than in 
2007 (6.5 %) (Tiemensma, 2010; Mole, 2019). It can be deduced from this data that the burden 
of SUD in South Africa is becoming a more prominent issue with each passing year.  
It is mandated in South Africa that SUD cases undergo medico-legal investigations to determine 
the cause of death (Regulations regarding the rendering of forensic pathology service, 2018). 
In the majority of these cases, the cause of death is ascertained through a combination of 
medico-legal autopsies, ancillary investigations and consideration of the case histories 
(Maluleke, 2018). It is at the discretion of the forensic pathologist to submit a specimen for 
ancillary testing, a choice which often depends on the case context (Regulations regarding the 
rendering of forensic pathology service, 2018). A study by de Jong (2017) found that 
approximately 63 % of cases admitted to SRM had requests for at least one ancillary test – of 
which, approximately 44 %, 16 % and 7% were blood alcohol-related, ballistic-related and 
histology, respectively (de Jong, 2017). Other ancillary tests, such as toxicology and 
pharmacology were performed at a far lesser rate (de Jong, 2017).  
Previous studies have identified a number of causes and risks related to SUD of all ages, 




heart disease or cardiac channelopathies (Tiemensma, 2010; de Luna & Elosua, 2012; Morris 
et al., 2016; Maluleke, 2018; Van Deventer, Rossouw & Du Toit-Prinsloo, 2016; Kruger et al., 
2018; Heathfield, Martin & Ramesar, 2019). In certain cases, despite a complete autopsy and 
ancillary investigations, the cause of death might still be undetermined; these cases are referred 
to as ‘negative autopsies’. 
Cause of death determination is essential for bringing closure to the relatives of the deceased 
as well as for clinical developments in treatments for pathologies related to these deaths 
(Etheridge & Saarel, 2014). However, the proportion of negative autopsies in SUD cases were 
reportedly up to 14 % in South Africa and between 5 % and 30 % in other regions across the 
globe (Lim et al., 2010; Tiemensma, 2010; Morris et al., 2016; Oscar & Ramon, 2016). This 
highlights the importance of developing alternative ancillary investigations which could further 
aid in determining cause of SUD in instances where the current approaches are not sufficient. 
1.1.2. Molecular autopsies  
Genetic investigations have shown value as an investigative tool in autopsy-negative SUD 
cases, as they have aided in the identification of underlying genetic variants which could have 
caused or contributed to death (Madea et al., 2010; Campuzano et al., 2014; Hata, Kinoshita & 
Nishida, 2017; Heathfield, Martin & Ramesar, 2018). This technique of analysing the genetic 
material of an individual for purposes of cause of death determination has come to be known 
as the ‘molecular autopsy’ (Madea et al., 2010).  
While molecular autopsies have not yet been introduced routinely in forensic investigations, 
research has demonstrated their success in aiding previously unresolved cases as well as in 
revealing medical information that could be used to screen at-risk relatives for the variants 
identified in SUD cases (Madea et al., 2010; Oscar & Ramon, 2016; Sanchez et al., 2016; Hata, 
Kinoshita & Nishida, 2017; Heathfield, Martin & Ramesar, 2018). Indeed, a systematic 
literature review showed that the cause of death was subsequently established in a median of 
32 % of previously unresolved SUD in young individuals, between ages 1 – 35 years old, 
through the use of molecular autopsies (Heathfield, Martin & Ramesar, 2018).  
It is largely hypothesised that concealed cardiac channelopathies contribute significantly to the 
high rate of autopsy-negative SUD, especially in young individuals (Campuzano et al., 2014). 
As a result, the majority of molecular autopsy research has been directed at identifying disease-




abnormalities, most commonly Long QT Syndrome, Brugada syndrome and Catecholaminergic 
polymorphic ventricular tachycardia (Campuzano et al., 2014; Brion et al., 2015; Heathfield, 
Martin & Ramesar, 2018; Heathfield, Martin & Ramesar, 2019). Mutations in the voltage-gated 
ion channels encoded by the KCNQ1, KCNH2 and SCN5A genes, which are responsible for 
encoding cardiac channels for potassium (K+) and Calcium (CA2+) ions, respectively, are 
among those implicated in sudden cardiac death (Tester et al., 2012; Hata, Kinoshita & Nishida, 
2017).  
Additional genetic variants, such as those related suicide as well as alcohol and drug 
metabolism have been identified as potential targets for molecular autopsy investigations (Cui 
et al. 2007; Heathfield et al, 2014). However, further research would be required to establish a 
panel of genes for these tests. In suicide cases, it may be of interest to investigate the expression 
of variant genes implicated in the increased susceptibility to suicidal behaviours (Cui et al. 
2007).  For instance, a mutation in the Regulator of G-protein Signalling 2 (RGS2) gene 
responsible for intracellular signalling has been shown to be associated with increased anxiety 
and aggressive behaviour, often leading to an increased risk of suicide (Cui et al. 2007).  
Fresh samples, such as blood or fresh-frozen tissues collected as part of the prospective case 
investigation, are currently the gold standard for genetic testing on post-mortem samples 
(Middleton et al., 2013). However, a retrospective molecular autopsy may be beneficial in 
reducing the current burden of unresolved SUDY cases, where prospective sampling is no 
longer an option. In such instances, the most likely biological material available in the archival 
storage is in the form of formalin fixed paraffin embedded tissues (FFPETs), which would have 
been obtained for routine histopathology analyses.  
FFPETs are preserved by treating tissue biopsies with formalin to fix the proteins and cellular 
structures within the tissues (Hewitt et al., 2008; Canene-Adams, 2013). Subsequently, the 
tissue is set in a block of immunohistochemistry-grade paraffin wax to facilitate the precise 
sectioning of the tissue (Canene-Adams, 2013). Formaldehyde, which is used in the fixative, 
forms chemical reactions with the DNA in the tissues resulting in denaturation or cleavage of 
the DNA strands (Srinivasan, Sedmak & Jewell, 2002). Furthermore, formaldehyde causes 
intra- and inter-molecular DNA and protein crosslinking (Srinivasan, Sedmak & Jewell, 2002; 
Do & Dobrovic, 2015; Donczo & Guttman, 2018). Thus, DNA yielded from FFPETs is 
typically of poor quality and highly degraded. The effect of formalin-fixation and paraffin-




amplification, consequently reducing the success of identifying genetic variants for molecular 
autopsies (Srinivasan, Sedmak & Jewell, 2002; Huijsmans et al., 2010; Do & Dobrovic, 2015). 
Despite the detrimental effects associated with FFPET regarding molecular analyses, this tissue 
still represents an extensive and largely untapped DNA repository (Kokkat et al., 2013). If the 
quality and quantity of DNA recovered from these tissues can be improved, through 
optimisation of the DNA extraction method, it would allow for deeper investigation into many 
cases which would otherwise remain dormant. As a result, retrospective molecular autopsies 
could be performed, which may ease the burden of unresolved SUDY cases at SRM. 
1.2. RATIONALE AND AIM OF LITERATURE REVIEW 
There are various potential approaches to optimising DNA recovery from different biological 
samples, including FFPETs. Previous studies have found that DNA quality and quantity 
recovered from FFPETs can be improved by adjusting variables such as the tissue type, 
chemical composition of the solvents and solutions and incubation temperatures for both 
commercially manufactured and conventional in-house methods (Huijsmans et al., 2010; 
Maraschin et al., 2017; Reid et al., 2017).  The aim of this literature review was to identify 
variables which have been investigated in previous research and to summarise and critically 
assess the relevance of the effects of these variables on the quality and quantity of DNA 
recovered from FFPETs.  
1.3. SEARCH STRATEGY 
The articles for this review were retrieved by performing a detailed search of PubMed, Web of 
Science and Scopus databases using keywords as shown in Table 1.1. Following the initial 
search, PubMed, Web of Science and Scopus yielded 88, 176 and 310 articles, respectively. 
The title and abstract of each article were screened for relevance and were excluded if they 
pertained to non-human specimens, focused on RNA or protein recovery as opposed to DNA 
recovery, focused on the identification of the causative effects of genetic variants as opposed 
to DNA recovery or if they were not available in English (Table 1.2.). Peer-reviewed, original 
articles and case reports were included, whereas literature reviews were excluded to avoid over-
representation of the data. Applying these criteria yielded 54 articles, 18 of which were 





Table 1.1. Keywords used in the search of PubMed, Web of Science and Scopus databases for literature 
pertaining to the optimisation of DNA extraction from formalin fixed paraffin embedded tissues. The 
‘OR’ command was used to run the alternatives; the ‘AND’ command was used to run the keywords.   
Keyword (AND) Alternatives (OR) 
Optimisation  Optimising; optimal; modification; develop 
DNA extraction  DNA purification; DNA isolation 
FFPET Formalin fixed paraffin embedded tissue; FFPE 
 
Table 1.2. Filtering process for exclusion of journal articles produced from a literature search of 
PubMed, Web of Science and Scopus.  
 
 
1.4. SEARCH RESULTS  
The quantity and quality of DNA extracted from FFPETs appeared to be dependent on a number 
of variables which fell within the tissue preparation and DNA extraction workflow (Figure 1.1). 
These included pre-fixation (tissue type, age and degree of autolysis), fixation (type of fixative 
and duration of fixation), post-fixation (storage, tissue preparation and processing) and DNA 
extraction variables (Gilbert et al., 2007). Previous research seemed to focus on the tissue 
























PubMed 88 24 32 6 15 0 11  
Web of 
Science 
176 11 91 15 42 2 15 
Scopus 310 11 182 23 63 3 28 
Tissue sampling 












Figure 1.1. Factors in the DNA extraction workflow which may affect the quality and quantity of DNA 




The articles reviewed in this study were critically analysed and information pertaining to the 
effect of a particular variable on DNA quantity and/or quality was highlighted. The table in 
Appendix A.1. summarises the results for the analysis of each of the 26 articles included in this 
review. The main findings have been synthesised in the text below.  
1.4.1. Tissue sampling  
The tissue processing methodology for FFPETs typically begins with the sampling of tissue 
blocks. Microtome sectioning is the most common sampling method for FFPETs and involves 
the removal of a thin layer from the tissue block using a steel blade. Alternatively, tissue can 
be removed from the block by needle biopsy (coring) or scraping with a sterile scalpel. Tissue 
coring only removes a small, often targeted portion of tissue, which would be advantageous for 
clinical diagnostic purposes as it allows for selection of specific portions of tissue that may be 
of interest (Patel et al., 2016). However, coring was not commonly used for forensic samples.  
Overall, microtome sectioning was performed in 81 % of the studies in this review, whereas 
scraping and coring were only used in 23 % and 8 %, respectively (Appendix A.1.). Studies 
wherein microtome sectioning was used reported successful DNA recovery and PCR 
amplification of fragments ranging from 90 base pairs (bp) to over 600 bp in size. However, 
there was great variability in the tissue sectioning parameters, i.e. tissue thickness and number 
of sections. Thus, a direct comparison could not be made for these studies. Various methods 
called for a range of one to 15 sections of 3-µm to 50-µm in thickness. Further research is 
warranted in assessing the effect of variable tissue sectioning parameters on DNA recovery.  
Two studies in this review directly compared the sectioning, coring and scraping methods with 
regards to the DNA yield and success of PCR amplification. One study reported that tissue 
cores yielded between 122 % and 132 % more DNA than tissue sections from clinical samples, 
which may be due to the coring process being more targeted than microtome sectioning 
(Bukhari et al., 2008; Chung et al., 2012). Regions on the tissue with the highest number of 
nuclei can be identified by cell staining and microscopy and selected for by coring (Patel et al., 
2016). However, it was further reported that tissue cores collected from autopsy material had 
lower DNA yields than those collected from surgical biopsies (Patel et al., 2016). These 
findings reiterate that while coring may be an effective method for cell selection, it may be 





Another study reported that while there was no difference in the DNA yield for equal amounts 
of tissues that had been sectioned or scraped, tissue sections had a slightly higher PCR success 
rate than scraped tissues (Bukhari et al., 2008). It appeared that microtome sectioning was 
considered a more suitable method than coring and scraping for DNA extraction from post-
mortem FFPET samples for downstream molecular analyses. However, due to variability in the 
literature with regards to the tissue sectioning parameters, there is room for additional research 
into the effect of tissue thickness and number of tissue sections on DNA recovery and PCR 
success rate.  
1.4.2. Tissue preparation 
Once the FFPET blocks have been sampled either by sectioning, coring or scraping, the tissue 
is then processed to make it more amenable to DNA extraction and downstream molecular 
analyses. Tissue processing involves the removal of the paraffin wax, also termed 
‘deparaffinisation’, followed by rehydration and homogenisation of the tissue. 
Deparaffinisation is arguably the most crucial step for successful DNA extraction as 
undissolved paraffin incorporated in the sample has been shown to inhibit PCR and cause 
inaccurate quantification results (Pikor et al., 2011).  
FFPETs can be mechanically or chemically deparaffinised. The most common deparaffinisation 
method used in the studies included herein, was chemical solubilisation, where 50 % of studies 
made use of xylene and 35 % made use of organic solvents (Bonin & Stanta, 2013; Kocjan, 
Hošnjak & Poljak, 2015). Since xylene is highly toxic and hazardous, the use of organic 
alternatives, such as limonene, hexane, pentane or mineral oil, were increasingly more common 
in recent years (Gilbert et al., 2007; Lin et al., 2009; Bonin & Stanta, 2013).  
Although a direct comparison cannot be made between studies which used xylene and organic 
solvent deparaffinisation methods, it was noted that DNA quantity, quality and PCR success 
rate was comparable for both methods. Furthermore, it was previously demonstrated that the 
organic solvent, pentane, produced comparable DNA yields with no difference in PCR success 
rate as compared to xylene (Gilbert et al., 2007).  
Some DNA extraction methods omitted the deparaffinisation solution completely and instead 
opted for solubilising agents or mechanical deparaffinisation methods such as melting of the 
wax by applying heat or pressure to remove the paraffin directly into the lysis buffer (Coombs, 




Hošnjak & Poljak, 2015). Heating and pressure cooking were used in 31 % and 8 % of the 
studies, respectively.  
Pressure cooking was the most recent development (first used in 2012) and has only been used 
in two studies in this review (Chung et al., 2012; Zhong et al., 2013). These studies reported no 
significant difference between pressure cooking and xylene deparaffinisation with regards to 
the DNA yield and PCR success rate. However, there were a number of confounding factors 
which could have influenced this result (Gilbert et al., 2007; Zhong et al., 2013). For instance, 
the studies used a small sample size and did not control for tissue type, tissue sampling method, 
tissue processing and DNA purification methods. Additional research is therefore required to 
generate empirical data to assess whether pressure cooking is indeed a suitable alternative to 
xylene.  
Four of the studies in this review (15 %) reported that heating methods yielded higher quantities 
of DNA with increased purity and up to 16 % increased PCR success rate as compared to xylene 
(Coombs, Gough & Primrose, 1999; Shi et al., 2002; Chung et al., 2012; Lagheden, Eklund, 
Kleppe, Unger, Dilner, et al., 2016). However, a limitation of their conclusions was that heating 
methods were often paired with other chemical (e.g. organic) solvents to facilitate the chemical 
reaction and further enhance the efficiency of deparaffinisation.  
Manufacturers of certain commercial DNA extraction kits have largely shifted away from using 
xylene, and instead have developed organic deparaffinisation solutions paired with the use of 
heated incubation (Kocjan, Hošnjak & Poljak, 2015). Overall, this seemed to be the best 
approach to the deparaffinisation of FFPETs, due to its similar DNA recovery to xylene, but 
with the added advantage of carrying far fewer health and safety risks (Coombs, Gough & 
Primrose, 1999; Shi et al., 2002; Atanesyan et al., 2017).  
1.4.3. Tissue digestion  
Deparaffinisation is typically followed by proteolytic tissue digestion in attempts to overcome 
the DNA and protein cross-linking caused by formaldehyde. Digestion is most commonly 
achieved by incubation with proteinase K (pro K), a highly active broad-spectrum serine 
protease that cleaves both native and denatured proteins, releasing the DNA (Bonin & Stanta, 




Many studies indicated that an extended incubation with pro K at an elevated temperature 
improved the efficiency of DNA extraction and PCR amplification of longer fragments (Shi et 
al., 2002, 2004; Dedhia et al., 2007; Gilbert et al., 2007; Huijsmans et al., 2010; Okello et al., 
2010; Kocjan, Hošnjak & Poljak, 2015). The majority (71 %) of studies in this review 
recommended and made use of DNA extraction protocols with a short 15-minute incubation at 
95 ℃ during the tissue lysis step, followed by overnight incubations at 55 – 65 ℃  (Huijsmans 
et al., 2010).  
The short 15-minute pre-incubation at 98℃ has been shown to improve DNA yield and PCR 
efficiency, which is often recommended by manufacturers of commercial DNA extraction kits 
(Gilbert et al., 2007; Huijsmans et al., 2010). Studies have reported that higher incubation 
temperatures resulted in an increase in DNA concentration and purity. However, this result was 
dependent on additional factors such as the chemical composition and pH of the digestion buffer 
as well as the incubation time (Shi et al., 2002, 2004; Dedhia et al., 2007; Gilbert et al., 2007).  
When a basic digestion buffer (pH 10 – 12) was used, incubation temperatures above 100 ℃ 
improved the DNA yield and PCR amplification of fragments up to 600 bp in length (Shi et al., 
2002, 2004). However, when the pH was reduced below 9 with incubation temperatures at 55 
℃ – 65 ℃, DNA yield and fragment length were significantly reduced (Shi et al., 2002; Dedhia 
et al., 2007; Gilbert et al., 2007). This has been attributed to the fragmentation of DNA that 
occurs at a combination of low pH and elevated temperatures (Gilbert et al., 2007).  
Similarly, the time of incubation was thought to be closely linked to the resultant DNA 
fragmentation associated with increased temperatures. Thus, a balance between time and 
temperature must be found to ensure minimal DNA degradation (Gilbert et al., 2007). Longer 
incubation times at lower temperatures (55 ℃ – 65 ℃) have been shown to improve DNA yield 
and successful amplification by quantitative polymerase chain reaction (qPCR) (Gilbert et al., 
2007; Okello et al., 2010). While no significant difference in DNA yield was seen when tissues 
were incubated for 4 hours and 24 hours, some studies have shown that increasing the 
incubation time further to 48 hours significantly enhanced PCR success (Gilbert et al., 2007; 
Snow et al., 2014). This phenomenon is based on the principle that incubation time and 
temperature is directly related to the thermal energy input, which in turn causes partial reversal 
of the DNA-crosslinks (Gilbert et al., 2007; Bonin & Stanta, 2013). Hence, as the thermal 
energy input increases, DNA-crosslinking decreases thereby making it more amenable to PCR-
amplification. When incubation time was increased above 48 hours, the increased PCR success 




This may be due to a plateau-effect in the ability to reduce DNA cross-linking, thereby limiting 
the success of PCR amplification (Gilbert et al., 2007).   
The variable chemistries, lysis times and temperatures for the DNA extraction methods used in 
previous studies made it challenging to standardise the incubation parameters for an improved 
DNA extraction method. Typically, manufacturers optimise the commercial DNA extraction 
protocols to their specific chemistries. It may be useful to modify these protocols to suit the 
laboratory setting or sample conditions. When using a strong basic digestion buffer, it may be 
beneficial to use higher temperatures and longer incubation times for an increased DNA yield 
and PCR efficiency. When using digestion buffers with a lower pH, it is recommended to limit 
the time and temperature to a maximum of 48 hours at 55 – 65 ℃.  
1.4.4. DNA purification 
The approach to DNA extraction ranges from conventional heat-treatment and phenol-
chloroform methods to commercially manufactured DNA extraction kits (Shi et al., 2004; 
Dedhia et al., 2007; Huijsmans et al., 2010; Wang et al., 2013). In 2015, there were 35 
commercial DNA extraction kits specifically designed for FFPETs available on the market 
(Kocjan, Hošnjak & Poljak, 2015). Most commercial kits were based on a similar principle; 
‘silica or resin adsorption technology’, which manipulates the binding affinities of silicates for 
DNA under various conditions of pH and salt concentration  (Kocjan, Hošnjak & Poljak, 2015).  
There are a number of advantages in using a commercial kit over a conventional in-house 
method. For instance, kits have reduced variability in their solutions, thereby increasing 
reproducibility. This might explain why commercial kits have been shown to improve DNA 
yield – as a result of a reduced observational error (Weirich et al., 1997; Bonin & Stanta, 2013). 
The main disadvantage of using commercial kits is that it is relatively costly. Furthermore, one 
study reported that despite the high cost of commercial DNA extraction kits, it did not yield 
sufficient DNA for PCR amplification (Dedhia et al., 2007). Overall, head-to-head comparisons 
between various laboratory-based and commercial kits produced variable results.  
The variability in the literature centres around the effects of in-house and commercial methods 
on the DNA extraction efficiency. Thirteen of the studies in this review directly compared the 
in-house phenol-chloroform-isoamyl alcohol (PCI) and cetyl trimethylammonium bromide 
(CTAB) methods to various commercial extraction kits. There was a split conclusion, where 




conventional methods, while the remainder of the studies reported the opposite (Dedhia et al., 
2007; Bonin et al., 2010; Huijsmans et al., 2010; Funabashi et al., 2012; Paireder et al., 2013; 
Wang et al., 2013; Oskina et al., 2017). This conflict of results may be attributed to the 
variability in the pre-analytical conditions, such as tissue processing methods and differences 
in the in-house protocols used in these eleven studies. 
In addition to DNA yield, six studies reported that commercial kits yielded DNA with higher 
purity measurements and longer DNA fragments (Coombs, Gough & Primrose, 1999; Gilbert 
et al., 2007; Huijsmans et al., 2010; Chung et al., 2012; Paireder et al., 2013; Wang et al., 2013). 
PCI extraction had significantly larger variation in the reported DNA quantities and purities. 
Thus, despite variability in the reports on DNA concentration, the overall consensus appears to 
be that commercial DNA extraction kits produce more accurate and precise results and are 
therefore more reliable for downstream molecular analyses (Ludyga et al., 2012; Oskina et al., 
2017).  
In the majority of studies which reported an improved DNA yield and PCR efficiency, the 
QIAamp DNA mini/micro or QIAamp DNA FFPE tissue kits were used. These studies reported 
that the purity of the DNA and reproducibility of the results from in-house methods were poor 
as compared to the Qiagen kits (Ludyga et al., 2012; Oskina et al., 2017).  
A comparison between the various commercial kits used across the studies in this review 
showed that the QIAamp DNA FFPE tissue kit, Wax-free DNA extraction kit, TrimGen’s 
WXF, Ambion’s RAD and Sigma’s GEN were among those which appeared to produce 
relatively high DNA yields. Of these, the QIAamp DNA FFPE tissue kit has been reported to 
be most suitable for FFPET specific amplification and best for larger fragment amplicons. Other 
kits, such as the truXTRAC FFPE DNA extraction kit has shown to yield competitive amounts 
of DNA, but with larger variability depending on the sample type (Kresse et al., 2018). 
The process of selecting a commercial DNA extraction kit is largely based on the aim and scope 
of the study and the laboratory requirements or restrictions. For instance, the tissue type, 
species, length of amplicon and potential downstream applications should be factored in when 
choosing between the DNA extraction technologies currently available. There are a number of 
commercial DNA extraction kits which have shown to yield DNA suitable for a multitude of 
downstream molecular processes (Kocjan, Hošnjak & Poljak, 2015; Atanesyan et al., 2017; 
Kresse et al., 2018). A molecular diagnostics focused laboratory might be highly motivated to 




laboratories may be more interested in automatic DNA extractions than those with smaller-
scale studies and non-clinical applications (Khokhar et al., 2012).  
1.5. RATIONALE  
There is great need for the development of an optimised DNA extraction protocol for use in a 
local context; specifically, for SRM. This would allow for further investigation, by means of 
molecular autopsy, into unresolved SUDY cases.  In order to identify candidate cases for 
inclusion in this study and for molecular autopsies on SUDY cases at SRM, additional 
epidemiological and descriptive information is needed. This data, which is sorely lacking in the 
literature, can be obtained by retrospective analysis of SUDY cases at SRM.  
Data obtained from the case review could prove essential for identifying pre-analytical variables 
that could affect DNA quality and quantity, such as tissue type, specimen storage time and 
circumstances surrounding death.  
A previous unpublished study in the research group compared DNA recovery from FFPET 
blocks of various tissue types. The tissue type did not seem to affect DNA recovery, however, 
a trend was seen where FFPET sections with a greater cell count yielded higher DNA 
concentrations. Thus, when multiple tissue types are available for a single case, microscopic 
quantification of the cell content may aid in establishing the best FFPET block for DNA 
extraction.  
In addition, the previous study showed that increasing the number of tissue sections of equal 
thickness was shown to improve DNA recovery when using three commercial DNA extraction 
kits, namely the NucleoSpin® DNA FFPE XS kit (Machery Nagel), ZR FFPE DNA MiniPrep™ 
kit (Zymo Research) and the QIAamp® DNA FFPE tissue kit (Qiagen). Results showed that the 
Qiagen kit yielded the best quality and quantity of DNA from FFPETs, followed by the Zymo 
Research kit.  
For each of these kits, there was comparable DNA recovery when using mineral oil and the 
commercial deparaffinisation solution. Furthermore, xylene did not appear to improve DNA 
extraction from FFPETs.  
Lastly, this previous study showed that neither DNA concentration nor DNA integrity was 




literature review provided insight into a number of variables that could affect retrospective 
DNA extraction from FFPETs. 
Building on this research, further optimisation of DNA recovery from FFPETs would enable 
retrospective DNA analysis for investigations into genetic causes of death and potentially 
reduce the burden of unresolved SUDY cases at SRM. Due to a large backlog in forensic 
casework, it would be beneficial to further assess the applicability of using the optimised DNA 
extraction method for samples that have been stored over time. In this case, a longitudinal study 
would allow for comparison of the DNA quality and quantity for FFPETs that have been 
collected more recently and those stored for multiple years.  
1.6. AIM AND OBJECTIVES 
The aim of this study was to investigate the use of FFPETs as a source of DNA in SUDY cases 
for the intended future application of molecular autopsies.   
The study objectives were to: 
i. Retrospectively analyse the Office Autopsy Database to identify and briefly describe 
SUDY cases admitted to SRM. 
ii. Optimise the DNA extraction procedure on FFPET samples from control SUDY cases 
admitted to SRM using the QIAamp® DNA FFPE tissue kit by adjusting the thickness 
and number of FFPET sections.  
iii. Assess the effect of thickness and number of FFPET sections on DNA quantity, purity 
integrity and fragment size. 
iv. Compare the concentration, purity, integrity and fragment size for DNA extracted from 





Chapter 2: Methods 
2.1. STUDY DESIGN 
This study had a quantitative, cross-sectional design, with both retrospective and prospective 
components. First, forensic cases admitted to SRM between 1 January 2014 and 31 December 
2018 were retrospectively reviewed. These data were primarily used as inclusion criteria to 
identify samples for the prospective, experimental phase of the study. Data from the 
retrospective study were further used to contextualise the outcomes of the study in terms of its 
pre-analytical factors.  
The prospective phase of the study assessed the independent variables of FFPET section 
thickness, number of sections and storage time on the dependent variables of DNA 
concentration, purity, integrity and fragment size, within a population of SUDY cases from 
SRM. 
This research was approved by the University of Cape Town (UCT), Faculty of Health Science 
Human Research Ethics Committee (HREC REF: 211/2019) (Appendix A.2.).  
2.2. RETROSPECTIVE IDENTIFICATION OF SAMPLES 
The Office Autopsy Database (OAD) (HREC REF: R036/2014) was used to identify cases and 
samples relevant to this study. Of the cases admitted to SRM for medico-legal investigation 
between 1 January 2014 and 31 December 2018 (n = 11 585 cases), 2940 cases (25 %) were 
admitted under the circumstances of SUD of all ages (Appendix A.3.). When assessed 
according to age, 1 168 cases were identified where the individual was between 1 and 40 years 
old at the time of death, herein to be referred to as SUDY.  
The medico-legal case files of the SUDY cases were reviewed in greater detail. Variables 
pertaining to the age, sex, cause of death, date of death, death scene environment, date of 
autopsy and specimen collection for ancillary investigations were recorded. The demographic 
information and availability of FFPETs were used to identify ‘control’ samples for the 
optimisation of DNA extraction (n = 3) and ‘test’ samples (10 ≤ n ≤ 25) for assessing the 
applicability of the optimised method on more relevant samples; i.e. tissues that were stored 




A case was considered for inclusion as a control sample if it was admitted to SRM between 1 
January 2018 – 31 December 2018, the interval between death and autopsy was less than five 
days, cause of death was determined and histology specimens had been collected and no longer 
needed for the medico-legal investigation (Figure 2.1.). Three cases were identified and FFPET 
blocks from these cases were collected from the in the histopathology repository (HREC REF: 
R037/2014). The FFPET blocks of three different tissue types from each of these three cases 
were included for optimisation of DNA extraction. Hence, a total of nine FFPET samples were 
included in the control sample set.  
A case was considered for inclusion as a test sample if it was admitted to SRM between 1 
January 2014 – 31 December 2017, and cause of death was undetermined (Figure 2.1.). Due to 
the lack of availability of FFPET specimens for research purposes, only cases from 2016 were 
included in the test sample set. This comprised of a total of 32 tissue types from 12 cases.   
  
 
Figure 2.1. Categorisation and sampling of forensic cases admitted to the Salt River mortuary between 




2.3. TISSUE QUALITY ASSESSMENT 
The FFPET blocks (representing the various tissue types available for each case) were given a 
quality score based on the presence of tears, total surface area and the total number of nuclei. 
To this end, a single 5-µm section was cut from each FFPET block using an Accu-Cut® 200 
rotary microtome (Sakura Fintek, Amsterdam, UK) with disposable blades (Feather®, Osaka, 
Japan). To prevent cross-contamination, the first three sections of each block were discarded, 
the microtome was sterilised and the blade was changed between blocks.  
Each tissue section was placed in a water bath set at 60 ℃ to facilitate its transfer to a Histobond 
glass slide (Paul Marienfeld GmbH & Co. KG, Lauda-Königshofen, Germany), then dried 
overnight in an incubator set at 65 ℃. The following day, the tissue sections were stained with 
hematoxylin and eosin (H&E) (Appendix A.4.). 
The samples were visualised using a Leica DM500 light microscope under 100 X magnification 
with LAZ EZ™ software (Leica, Heerbrugg, Germany). The total surface area and the total 
number of nuclei present in each slide were quantified on the microscopic images using ImageJ 
software v1.46r (National Institutes of Health, USA). The various tissue types for each case 
were ranked according to the number of tears and the number of nuclei per total surface area.   
2.4. DNA EXTRACTION  
Based on preliminary data, it was hypothesised that finer sections would yield greater DNA 
qualities and quantities and that increasing the number of sections of equal thickness would 
improve DNA recovery. To test this, the thickness and number of FFPET sections were varied 
in the control samples.  
The FFPET blocks representing the tissue types with the highest quality score for the control 
samples, as quantified by microscopy, were sectioned to 5-µm, 3-µm and 1-µm thick (Figure 
2.2.). The number of tissue sections was incrementally increased from 5 to 100 sections. This 
was done in a staggered manner to avoid depleting the tissues. The best combination of 
variables (thickness and number of sections) was established by quantification of DNA 
recovery for the three control cases, as described in section 2.5 below.  
The DNA recovery for FFPETs that had been stored for a number of years was assessed. FFPET 
blocks representing the tissue type with the highest quality score for each of the test samples, 




FFPET sections were subjected to DNA extraction using the QIAamp® DNA FFPE tissue kit, 
according to the manufacturer’s instructions (Qiagen, Hilden, Germany) with the following 
modifications: 320 µl Deparaffinisation solution (Qiagen, Hilden, Germany) was used, tissue 
lysis was performed at 56 ℃ (900 rpm) for 20 hours on a Thermo-Mixer C (Eppendorf, 









2.5. DNA QUANTIFICATION 
2.5.1. NanoDrop™ Spectrophotometry  
The purity of the samples was quantified using the NanoDrop™ 2000 spectrophotometer as per 
the manufacturer’s instructions (Thermofisher Scientific, Wilmington, USA). Buffer ATL was 
used as a blank measurement and a 2-µl aliquot of each sample was used for quantification. 
The DNA purities were measured according to the A260/A280 and A260/A230 ratios. Samples 
were considered free of protein and organic compounds or chaotropic salt contaminants if the 
A260/A280 and A260/A230 ratios were above 1.8 and 2.0, respectively. 
2.5.2. qPCR 
The effective DNA concentration was quantified by qPCR using the Quantifiler™ Trio DNA 
quantification kit, according to the manufacturer’s instructions (Thermo Fisher Scientific, 




California, USA). Each sample was quantified alongside a five-step serial dilution of standard 
DNA (50 ng/μL to 0.005 ng/μL), processed on a 7500 Real-Time PCR instrument with the HID 
Real-Time PCR Analysis software v.1.2. (Applied Biosystems, California, USA).  
This DNA quantification kit implements two human autosomal markers, one of 80 bp and 
another of 214 bp in size. The DNA concentration was automatically quantified using the Ct 
values for the small and large autosomal amplicons. An internal positive control (IPC) was 
present in each sample to indicate the proper functioning of the assay and the presence of PCR 
inhibitors. Samples with IPC Ct values greater than 31 were considered to have significant PCR 
inhibition (Brooks et al., n.d.; Applied Biosystems, 2017).  
2.5.3. TapeStation 
The integrity and fragment length of each sample was analysed by subjecting samples to digital 
capillary electrophoresis, using the 4200 TapeStation System with the Genomic DNA 
ScreenTape® assay, according to the manufacturer’s instructions (Agilent Technologies, 
Waldbronn, Germany).  
The DNA integrity number (DIN) was automatically generated for each sample by assessing 
the distribution of signal as compared to the lower DNA marker. DIN values range from 1 to 
10; with 1 being highly degraded and 10 being completely intact DNA. Samples with DIN 
values below 3 were considered severely degraded (Petersen et al., 2016; Jung, Ji & Schmidt, 
2017).  The fragment sizes were automatically quantified against the Genomic DNA ladder and 
the DNA concentrations for the area under the peak of each sample was quantified against the 
known concentration of the lower marker. 
2.6. Statistical analyses 
Statistical analyses and visualisation of the data were performed using the Prism software v.8.3 
(Graphpad, California, USA). Descriptive statistics were performed on all variables to 
determine the measures of central tendency and dispersion.  
Categorical variables, including the number of cases, age, sex, environmental factors and days 
between death and autopsy were assessed using the χ2 test. Each category included the total 




the categories was analysed individually. P-values less than 0.01 were considered statistically 
significant.  
Numerical data, including the DNA concentrations, purities and integrities were assessed using 
ANOVA. For comparisons between tissues of various thickness, the data were grouped into 5-
µm, 3-µm and 1-µm sections. A one-way ANOVA with Tukey’s multiple comparison’s test 
was done on each of the groups. For assessing the effect of the number of sections on DNA 
recovery, a two-way ANOVA with Sidak’s multiple comparison’s test was done on the 
combined set of data. P-values less than 0.05 were considered statistically significant.  
For assessing the effect of storage time on DNA concentration, purity and integrity, a Pearson’s 
correlation was performed. R-values closer to 1 or -1 indicated a strong correlation, whereas 















Chapter 3: Results 
3.1. CASE REVIEW 
All data collected for the control and test samples were summarised in Appendix A.5. The main 
findings were synthesised in the text below and information for individual cases are available 
on request and upon approval from the Director of Forensic Pathology Services.  
3.1.1. Outcomes of post-mortem investigations 
A total of 1 168 SUDY cases were admitted to SRM over the 5-year study period. There was 
an increase in SUDY admittance from 137 cases in 2014 to 334 cases in 2017, with a slight 













Figure 3. 1. Outcomes of post-mortem investigations for the total number of SUDY cases admitted to 




The outcomes of the post-mortem investigations into these cases revealed natural and unnatural 
causes of death in 806 (69.01 %) and 48 (4.11 %) cases, respectively (Figure 3.1.). The cause 
of death in 305 (26.11 %) cases were undetermined at the time of the study.  
Specimens for histopathology analysis were obtained at autopsy for 416 (35.62 %) SUDY cases 
over the 5-year period.  A significantly larger proportion of undetermined SUDY cases (56.73 
%) had histopathology specimens taken as compared to cases reported to have occurred from 
natural (p < 0.0001) and unnatural causes (p < 0.0001) (Figure 3.1.).  
Histopathology specimens obtained at the time of autopsy are routinely fixed in formalin and 
embedded in paraffin for histological analysis. However, not all of these are available for 
research purposes. Natural causes of death were reported for two of the three control cases used 
for the optimisation of DNA extraction; the third being an unnatural death (Appendix A.5.).  
3.1.2. Post-mortem environmental conditions 
The death scene environment and time between death and autopsy were recorded for the total 
SUDY cases at SRM.  
The majority of SUDY cases (69.52 %) at SRM were reported to have indoor death scene 
environments. A further 13.86 % and 16.61 % had outdoor and unspecified death scene 
environments, respectively.  
The majority of cases (75 %) were autopsied within five days of death (mean = 4.08 days; 
median = 3 days). The largest interval between death and autopsy for SUDY cases at SRM was 
97 days, however, this was identified as an outlier in the population. 
3.1.3. Population demographics  
There was a disproportionate number of cases across the age range between one and 40 years 
old. The majority of SUDY cases (75 %) at SRM were above the age of 25 years at death 
(Figure 3.2.). The age category of 39 – 40 years old had the highest number of deaths (n = 90) 
over the 5-year period. The three cases in the control sample included in this study were 23 
years, 34 years and 39 years of age at death. The test sample was more diverse with regards to 




When comparing male to female subpopulations, a similar trend was seen as described above 
for the total number of cases. However, there were significantly more males than females 
overall (p = 0.0007). This trend was not seen for the control or test samples; as there were 








3.2. OPTIMISATION OF DNA EXTRACTION 
3.2.1. Tissue thickness 
Microscopic quantification of FFPET quality showed which tissue types had the greatest 
number of nuclei per total surface area. For the control sample set, brain and lung tissue were 
generally of better quality as compared to pancreas, kidney and heart tissues which were 
available (Appendix A.5.). The FFPET from the brain and lung from each of the control cases 
was then sectioned in varying thicknesses, and DNA was extracted to assess the relationship 
between tissue thickness and effect on DNA concentration, purity and integrity.  
Figure 3. 2. Age distribution according to sex for the total number of SUDY cases admitted to Salt River 




Figure 3. 3. The effect of FFPET thickness on DNA concentration as quantified by qPCR of (A) 80 bp 
marker and (B) 214 bp marker. (n): number of samples which were too degraded to amplify. (*): p < 
0.05. 
The median DNA concentrations (in a final volume of 50 µl) and total DNA yields were 
reported for each tissue thickness (Appendix A.6.). A comparison between DNA concentrations 
of 5-µm, 3-µm and 1-µm sections revealed that finer sections produced greater DNA yields 
(Figure 3.3.).  
There was a noticeable, but not significant, difference in DNA concentrations of the small 
marker for 1-µm and 3-µm sections (p = 0.08).  Moreover, there was a significant difference in 
DNA concentrations for 1-µm and 5-µm sections (p = 0.0427). For the large marker, the 
concentrations for the 1-µm and 5-µm sections were noticeably, but not significantly different 
(p = 0.0617), whereas DNA concentrations for the 1-µm and 3-µm sections were significantly 
different (p = 0.0493). 
While there was ambiguity regarding whether the 3- and 5-µm thick sectioning significantly 



















Figure 3. 4. The effect of FFPET thickness on DNA purity as measured by NanoDrop™ 
spectrophotometry absorbance at A260/A230 and A260/A280. Red dotted lines indicate the threshold 
for pure DNA. (**): p < 0.05; (***): p < 0.005; (****): p < 0.0005. 
The DNA purities for FFPETs of varying thicknesses were also assessed. Results showed that 
there was a significant increase in both the A260/A230 (p = 0.0093) and A260/A280 (0.0005) 
purity ratios when the tissue thickness was reduced from 3-µm to 1-µm (Figure 3.4.). An even 
greater difference was seen when comparing the A260/A230 (p = 0.0001) and A260/A280 (p 
< 0.0001) ratios for tissues of 5-µm to 1-µm in thickness. Similar to the results for the DNA 
concentrations, there was no significant difference between the 3-µm and 5-µm sections for 
either purity ratio.  
Overall, there was less variability in the A260/A280 ratios, with the majority of 1-µm sections 
being within the threshold for pure DNA. While there was more variability in the A260/A230 
ratios, a large proportion of 1-µm sections were within or far above the threshold, suggesting 
















Results from the Genomic DNA ScreenTape® assay revealed that the tissue thickness 




3-µm and 1-µm sections, respectively (Figure 3.5.). This indicates that while all samples were 
of poor integrity, there was significant difference in DIN when tissue thickness was reduced 
from 5-µm to 3-µm (p = 0.0425), from 3-µm to 1-µm (p = 0.0265) and from 5-µm to 1-µm (p 














There was a high degree of variability in the fragment lengths for all samples, despite the tissue 
thickness. Finer tissue sectioning improved the yield of larger DNA fragments. Specifically, 55 
% and 22 % of 1-µm and 3-µm sections had fragments larger than 400 bp, respectively, whereas 
none of the 5-µm sections yielded fragments larger than 400 bp in size (Appendix A.7.).  
Therefore, results from the assessment of tissue thickness revealed that thinner sectioning 
improved DNA concentration, purity and fragment length, but not DNA integrity. Using this 
information, 1-µm sections were deemed to be better overall and was thus used in subsequent 
optimisation steps and experiments.  
Figure 3. 5. The effect of FFPET thickness on DNA integrity number (DIN) as quantified by the 
Genomic DNA ScreenTape® assay for highly degraded DNA. The red dotted line indicates the threshold 
for highly degraded DNA. (n): number of samples which fell outside of the range for DIN quantification. 




Figure 3. 6. The effect of number of FFPET sections on DNA concentrations as quantified by qPCR of 
(A) 80 bp marker and (B) 214 bp marker. (n): number of samples out of six which were too degraded 
to amplify. (*): p < 0.05; (**): p<0.005 
3.2.2. Number of tissue sections 
The effect of the number of tissue sections (30, 50 and 100 sections) on DNA recovery was 
reported, using 1-µm thick sections (Appendix A.6.). 
While no difference in DNA concentration was observed for 30 and 50 sections, a further 
increase from 50 to 100 sections significantly improved the concentrations of the small marker 
(p = 0.006) (Figure 3.7.). Moreover, a significant difference was observed for 30 as compared 


















An increase in the number of FFPET sections (1-µm thick) did not have any effect on the DNA 




Figure 3. 7. The effect of number of FFPET sections on DNA purity as assessed by NanoDrop™ 
spectrophotometry absorbance at A260/A230 and A260/A280. Red dotted lines indicate the threshold 
for pure DNA. 
DNA. As was seen previously, there was far greater variability in the A260/A230 than the 
A260/A280 ratios, however, there was no significant difference in purity ratios for the various 














All FFPET sections (1-µm thick) had DIN values below 3, indicating a high degree of 
fragmentation. There was no difference in the reported DIN values for 30, 50 and 100 sections 
(Figure 3.8.). Moreover, there were similar mean fragment lengths and proportions of fragments 
greater than 400 bp in size for the various numbers of tissue sections. Thus, increasing the 

















3.3. TESTING THE OPTIMISED DNA EXTRACTION METHOD 
The best tissue thickness and number of tissue sections was established from assessment of the 
results for DNA concentration, purity, integrity and fragment length. It was established that 100 
sections of 1-µm thick yielded the highest DNA concentrations, with the greatest purity ratios 
and a larger proportion of DNA fragments greater than 400 bp in size.  
Using these variables, DNA was extracted from stored FFPET blocks representing the tissue 
with the best quality for each of the test samples (Appendix A.5.). The effect of storage time on 
DNA concentration, purity and integrity was reported.  
Results showed that a median of 320 ng (287 ng – 698 ng) of DNA was recovered from FFPET 
samples that had been stored for up to three years (Appendix A.6.). The DNA concentrations 
were only slightly reduced for FFPETs stored for longer periods of time (Figure 3.8). However, 
the decrease over time was not statistically significant. Furthermore, when taking the 
confidence interval for the p-value into consideration, there was no strong evidence to indicate 
that the inverse correlation between time and DNA concentration was biologically relevant.  
 
Figure 3. 8. The effect of number of FFPET sections on DNA integrity number (DIN) as quantified by 
the Genomic DNA ScreenTape® assay for highly degraded DNA. The red dotted line indicates the 















There was a similar reduction in DNA purity with increased FFPET storage time (Figure 3.9). 
There was a weakly significant inverse correlation (p = 0.046) between time and A260/A230 

















































Figure 3. 9. DNA concentrations for 100 FFPET sections of 1-µm thick stored over a period of 450 to 
1 350 days (1-3 years), as quantified by qPCR for (A): 80 bp marker and (B) 214 bp marker. (n=16). 
Figure 3. 10. DNA purities for 100 FFPET sections of 1-µm thick stored for 450 to 1 350 days (1-3 
years), as quantified by spectrophotometry absorbance at (A) A260/A230 and (B) A260/A280. (n=16) 




The integrity values for all FFPETs stored between one and three years were below DIN 3, 
indicating a high level of fragmentation. There was a slight decrease in DIN for samples stored 
over time (Figure 3.10.). The oldest samples had an approximate 50 % reduction in DIN than 
fresher samples overall. However, this slight decrease was not statistically significant.  
In addition, 67 % and 45 % of cases from 2016 and 2018, respectively, had fragments greater 











DNA recovered using the optimised sectioning parameters for FFPETs stored between one and 
three years did not appear to be affected by the pre-analytical conditions measured. There were 
no significant correlations between DNA recovery (in terms of concentrations, purities and 
integrities) and age or sex of the deceased. Furthermore, there was no correlation between DNA 
recovery the number of days between death and autopsy for specimen collection. However, due 
to lack of variability in the sample set and the small sample size, a comparison between death 




Figure 3. 11. The effect of storage time (1-3 years) on DNA integrity number (DIN) as assessed by the 




Chapter 4: Discussion and conclusion 
4.1. BURDEN OF UNRESOLVED SUD CASES 
The SRM serves the West Metropole of the City of Cape Town in the Western Cape (South 
Africa). Upwards of 3 000 cases are received in this mortuary annually, which is relatively high 
as compared to most medico-legal centers in the Western Cape (de Jong, 2017).  
This study showed that there was a large proportion of cases admitted to SRM under the 
circumstance of SUD, with approximately 40 % of these occurring in the young. The number 
of SUDY admissions at SRM continued to rise, as was demonstrated with the 2.3-fold increase 
in SUDY admittance over the 5-year study period. This is concerning, especially since 
investigations into SUDY cases admitted to SRM did not reveal cause of death in 26 % of cases. 
This may have been due, in part, to the proportional increase in the overall percentage of SUD 
cases admitted to SRM during the study period. 
The number of unresolved SUDY cases at SRM was far greater than the range previously 
reported for negative autopsies in SUD of all ages nation-wide (Tiemensma, 2010; Morris et 
al., 2016). This might suggest the need for research into ancillary investigations that can be 
used to further investigate and resolve negative autopsies in SUDY at SRM, including post-
mortem genetic testing for determination of cause of death (Du Toit-Prinsloo & Saayman, 2012; 
Etheridge & Saarel, 2014; Sanchez et al., 2016; de Jong, 2017).  
However, it is of great concern that more than 50 % of all ancillary tests conducted during this 
study period had not been concluded and the results thereof not reported. Had this information 
been available, it could have been used to assist cause of death determination, ultimately 
reducing the number of unresolved SUDY cases. There are a number of reasons for incomplete 
ancillary testing, including backlogs in forensic case work and financial and staff constraints, 
which may extend or delay the time it takes for reports such as toxicological analyses to be 
returned by several months or even years (de Jong, 2017).  
In South Africa, there is a shortage of genetic specialists that would be available for performing 
molecular autopsies on these unresolved SUD cases. This would place the additional pressure 
on forensic laboratories above and beyond the current burden on these institutions (du Toit-
Prinsloo, 2012). Training of additional staff and equipping facilities for performing molecular 




This poses a major logistical consideration that would need to be overcome before molecular 
autopsies can be made routine in post-mortem investigations of unresolved SUD cases. 
The epidemiological information for the SUD population at SRM had not been evaluated in 
previous research. This study added some of the first quantitative data regarding the burden of 
unresolved SUD cases currently faced by SRM and highlights the need for additional research 
to investigate and identify risk factors in this population.  
4.2. IMPROVED DNA RECOVERY 
An improved method for DNA extraction from FFPETs of SUDY cases at SRM was developed. 
The combination of microscopic quantification of total nucleic acid content and adjusting the 
sectioning parameters, significantly improved DNA recovery in terms of the DNA 
concentrations, purities and amplification of larger fragment sizes.   
The nucleic acid content per total surface area, as quantified by microscopy, was particularly 
useful in this study by eliminating FFPET blocks with little to no nucleic acid content, 
ultimately saving on time and resources. Once the appropriate FFPET block was selected for 
DNA extraction, optimisation of the tissue sectioning parameters, namely the thickness and 
number of FFPET sections, was shown to significantly improve DNA recovery.  
4.2.1. Tissue thickness  
The thickness of the FFPET sections used in DNA extraction was shown to have an effect on 
overall DNA recovery. Finer sectioning of FFPETs significantly improved DNA yield, with a 
median of 288 ng (36.5 ng – 856 ng) of DNA extracted from 1-µm thick sections, regardless of 
the number of sections used (Appendix A.6.). This represents an 8.8-fold and 26.8-fold increase 
from 3-µm and 5-µm sections, respectively.  
The improved DNA yield with finer tissue sectioning is in accordance with the results of a 
previous study, which reported that sections thicker than 2-µm yielded significantly lower DNA 
quantities when the digestion time was less than 48 hours (Weiss et al., 2011). Authors 
purported that finer sectioning may improve tissue homogenisation and digestion, which in turn 
improves the DNA yield.  Since additional factors, such as incubation time and temperature 




were kept constant in this study (as informed from the literature review). It can therefore be 
deduced from the results of this study, that the improved DNA concentration was a direct result 
of finer FFPET sectioning.  
In addition to the amount of DNA recovered, DNA purity was shown to improve with finer 
FFPET sectioning. All DNA samples extracted from 1-µm thick sections were above the 
threshold for pure DNA, with a median A260/A280 ratio of 1.8. This represents a 1.3-fold and 
1.4-fold increase in A260/A280 ratios for 3-µm and 5-µm sections, respectively. The 
improvement in DNA purity with finer sectioning was more pronounced in the A260/A230 
ratios, where 1-µm sections had a median ratio of 1.7 as compared to 0.7 and 0.5 for 3-µm and 
5-µm sections, respectively.  
Previous studies that used the QIAamp® DNA FFPE tissue kit also observed this trend with 
regards to DNA purity. Due to many confounding variables, it was not possible to draw direct 
comparisons between results from these studies, however, FFPET sections ≤ 8-µm, yielded 
DNA with A260/A280 ratios from 1.78 – 2.52, as compared to 10-µm thick FFPET sections 
which yielded DNA with A260/A280 ratios from 1.37 – 2.04 (Ludyga et al., 2012; Turashvili 
et al., 2012; Sengüven et al., 2014; Snow et al., 2014; Atanesyan et al., 2017; Watanabe et al., 
2017; Carlsson et al., 2018). There was no indication in the literature of the effect of tissue 
thickness on A260/A230 ratios, as these were not commonly reported in the studies where the 
QIAamp® DNA FFPE tissue kit was used. Overall, these data indicated that finer tissue 
sectioning yielded DNA of greater purity, which is further supported by the results observed in 
this study.   
Lastly, the thickness of FFPET sections used in DNA extraction was shown to significantly 
affect the DNA integrity. However, unlike DNA concentrations and purity, DIN was shown to 
decrease with finer sectioning. All samples used in this study had DNA integrity values below 
five (Figure 3.7). This result was expected since it has been established that the process of 
formalin fixation results in DNA fragmentation (Srinivasan, Sedmak & Jewell, 2002; Do & 
Dobrovic, 2015; Donczo & Guttman, 2018). When sectioning was reduced to 1-µm, the 
integrity values were further reduced below three. This suggested a higher degree of DNA 
fragmentation with finer sectioning. 
However, when analysing the DIN values against the results from the digital capillary 
electrophoresis, it became evident that the decrease in DIN for 1-µm sections may be attributed 
to the larger proportion of fragments with a high molecular weight (MW). When the tissue 




DNA fragments above 400 bp in size (Figure 3.10.). Since the DIN is a ratio of the concentration 
of fragments relative to the small fragment in the DNA ladder, the presence of large fragments 
actually reduces the DIN. Thus, the interpretation of DIN in the context of severely degraded 
tissue may need to be reconsidered.  
The fragment sizes yielded from thinner sections in this study is in accordance with previous 
studies, which demonstrated successful amplification of fragments up to 400 bp in size (Wu et 
al., 2002; Lin et al., 2009; Hühns, Röpenack & Erbersdobler, 2015). While there was an 
apparently lower DIN (i.e. higher degree of fragmentation) in finer sections, there actually was 
a greater success for obtaining larger fragments than was seen for thicker FFPET sections. 
Overall, by employing a DNA extraction method with tissue sectioning as thin as 1-µm, DNA 
recovery from FFPET was improved. As was indicated by the literature review, previous studies 
made use of FFPET sections between 3-µm and 50-µm. This study demonstrated that reducing 
the thickness of FFPET sections to 1-µm, significantly improved DNA concentrations, purities 
and fragment lengths.   
4.2.2. Number of tissue sections 
In considering the results of the research previously conducted by this research group, 
increasing the number of tissue sections of equal thickness was expected to improve DNA 
recovery from FFPETs. However, this strategy was not previously applied to FFPET sections 
as fine as 1-µm thick.  
This study showed that there was significant variation in the DNA quantities for 1-µm thick 
sections, which appeared to be dependent on the number of sections used. The DNA 
concentrations were almost quadrupled when the number of tissue sections was just doubled 
(from 50 to 100 sections) (Figure 3.4.) This was expected, since increasing the number of tissue 
sections ultimately increases the input starting material for DNA extraction. This was supported 
by the comparison of two previous studies, one which yielded 1 280 ng of DNA from seven 
FFPET sections and another which yielded a median of 220 ng of DNA from two FFPET 
sections of equal thickness, using the QIAamp DNA FFPE tissue kit (Ludyga et al., 2012; 
Turashvili et al., 2012).  
Interestingly, DNA concentrations were not improved with smaller increases in the number of 




previous literature, is an important factor to consider when assessing the eligibility of a FFPET 
block for molecular autopsy investigations. It was not clear from the data generated in this 
report, what the ideal number of tissue sections for optimal DNA recovery was. However, this 
data indicated that samples with extremely low DNA content would require large amounts of 
starting material to significantly improve DNA recovery from FFPETs. This could be a limiting 
factor in cases where only a small amount of FFPET is available. It may be beneficial to direct 
future research at further investigating the relationship between DNA yield and number of 
tissue sections on a more incremental level. This may be particularly useful in cases with limited 
FFPET, which are being considered for downstream molecular analyses.  
Neither the purities nor the DNA integrities were affected by an increase in the number of tissue 
sections of equal thickness. Overall, there was more variability in the A260/A230 ratios, 
indicating less efficient removal of organic compounds or chaotropic salt contaminants. While 
the A260/A230 ratios were not commonly reported in studies where the QIAamp DNA FFPE 
tissue kit was used, two studies reported A260/A230 ratios between 1.6 and 2.58 (Ludyga et 
al., 2012; Turashvili et al., 2012). However, these studies did not control for tissue thickness 
nor any of the additional confounding factors reported, in the literature, to affect DNA purity.  
While not much is known regarding the effect of FFPET sectioning on DNA integrity, it is 
largely reported in the literature that DNA integrity is affected by incubation times and 
temperatures, as it is related to DNA fragmentation (Shi et al., 2002, 2004; Dedhia et al., 2007; 
Gilbert et al., 2007; Huijsmans et al., 2010; Okello et al., 2010; Snow et al., 2014; Kocjan, 
Hošnjak & Poljak, 2015). The incubation temperatures in this study were kept constant. It 
would be beneficial to further optimise the method developed in this study to improve DNA 
integrity by adjusting the incubation times and temperatures, particularly when a large number 
of sections are used.  
4.2.3. Storage time 
The DNA concentration, purity and integrity were not significantly associated with storage time 
for the FFPET blocks, which had been stored for up to 3 years. This is in accordance with 
previous research, which reported minimal DNA degradation for samples stored for two to 47 
years, including the pilot study previously conducted by this research group (Wu et al., 2002; 
Funabashi et al., 2012; Niland et al., 2012; Kokkat et al., 2013; Zhong et al., 2013; Nechifor-




The only statistically significant reduction over time was seen with the A260/A230 ratios. This 
would indicate less efficient removal of organic compounds or chaotropic salt contaminant in 
older samples. However, as was seen during the optimisation of DNA extraction, there was 
more variability in the A260/A230 than the A260/A280 ratios, which may have contributed to 
the relationship observed between purity and storage time. The sample size would need to be 
increased in order to make a stronger conclusion on the biological significance of this potential 
inverse relationship.  
Overall, this study serves as a good indication on the effect of FFPET sampling on the DNA 
concentration, purity and integrity for samples stored up to three years for its potential use in 
retrospective molecular autopsies of SUDY cases at SRM. However, there is still room for 
improvement on the DNA recovery to meet the requirements of molecular autopsy 
investigations.  
4.3. ELIGIBILITY FOR POSTMORTEM GENETIC TESTING 
There are numerous sequencing technologies that can be employed to perform a molecular 
autopsy, each with associated advantages and limitations. A previous study suggested the use 
of a targeted approach to molecular autopsies. For instance, a four-gene panel has been 
identified for investigation into sudden cardiac death in the young (Semsarian, Ingles & Wilde, 
2015). It is recommended to validate and confirm the presence of a genetic variant by Sanger 
sequencing and to use a multidisciplinary approach to interpreting the results in terms of 
causality to avoid false positives (Mcguire et al., 2014; Semsarian, Ingles & Wilde, 2015).  
More recently, the development of massively parallel sequencing (MPS), commonly referred 
to as next-generation sequencing (NGS) technologies are becoming more popular for post-
mortem genetic testing, as it is a high throughput system, making sequencing of genes more 
time- and cost-efficient (Brion et al., 2015). This technology allows for sequencing of more 
comprehensive gene panels and even whole-exome sequencing (WES) (Semsarian, Ingles & 
Wilde, 2015; Lahrouchi, Behr & Bezzina, 2016). In turn, screening for genetic variants are 
made easier and more robust in cases where no structural abnormalities were found at autopsy, 
thereby improving the likelihood of successful molecular autopsy. Hence, negative SUDY 
cases may benefit from NGS for cause of death determination above other strategies for 




The quantity and quality of the DNA sample affects the ability to perform NGS (Brion et al., 
2015; Arreaza et al., 2016). The minimum DNA quality and quantity requirements vary 
depending on the intended NGS application (Arreaza et al., 2016). Certain targeted DNA 
sequencing assays require as little as 1 – 10 ng DNA, while others require up to 200 ng DNA 
(Edinburgh Genomics, 2019). In this regard, by improving DNA recovery from FFPETs, the 
method developed in this study yielded sufficient DNA for an array of NGS applications. These 
results held true for samples that had been stored for up to three years (Figure 3.8.), which is a 
good indication that there is potential for using FFPETs in retrospective molecular autopsy 
investigations.   
In addition to DNA quantity, certain quality criteria need to be met for successful NGS analysis. 
Optimally, DNA with a high molecular weight (MW) and low levels of fragmentation should 
be used (Arreaza et al., 2016). If the DNA does not meet these requirements, the library 
preparation and DNA sequencing results may be compromised. More specifically, insufficient 
DNA integrity can affect the read depth and cause allele dropout (Brion et al., 2015).  
When using the DNA extraction method developed in this study, a greater proportion of high 
MW fragments were recovered. With this in mind, it appears that finer sectioning would expand 
the range of target genes that could be included in NGS analysis, consequently improving the 
success of molecular autopsy. In certain instances, the DNA size requirements can be adjusted 
if there is sufficient DNA and if the amplicon of interest is shorter than the smallest fragment 
in the sample (Corcoll et al., 2017; Edinburgh Genomics, 2019). This information can be used 
to assist in selecting appropriate markers and sequencing technologies for molecular autopsy. 
Taking the results from this study into consideration, it is recommended that if sequencing of 
fragments larger than 400 bp is required, it would be beneficial to reduce the thickness of 
FFPET sectioning as low as possible (in our laboratory, 1-µm), thereby improving the yield of 
larger DNA fragments.  
It may be worthwhile to explore ways to further enhance the proportion of DNA with a high 
MW, as this would improve DIN values for DNA extracted from FFPETs. Previous studies 
have reported a correlation between the DIN and NGS quality criteria. The coverage and on-
target sequencing for WES using the HiSeq 2500, 300 and 4000 systems were reportedly 
reduced for samples with DIN values below 3 (Petersen et al., 2016; Jung, Ji & Schmidt, 2017). 
The High Throughput Sequencing Unit at the German Cancer Research Center has established 
a threshold of DIN 7. If samples are below this threshold, there is no guarantee of successful 




Schmidt, 2017). However, another study, which reported a direct correlation between DIN and 
NGS library functionality showed that samples with a DIN value as low as 2.05 produced 
functional libraries (Millán-Esteban et al., 2018). When using the DNA extraction method 
developed in this study, all FFEPTs yielded DNA with DIN below 3. This highlights the need 
for further optimisation of DNA extraction to improve the DIN values for DNA extracted from 
FFPETs.   
In addition to the variables tested in this study, there are a number of pre-analytical variables 
which could contribute to DNA quality. It has been hypothesised that age, sex, death scene 
environmental factors and time between death and tissue collection play a role in DNA 
degradation, consequently reducing DNA integrity (Niland et al., 2012; Bass et al., 2014; Reid, 
Martin & Heathfield, 2019). In this study, there were no significant differences between these 
demographic variables and the DNA metrics that were measured. Hence, no inferences could 
be made on the effect of these variables on DNA recovery from FFPETs, but this should be 
assessed in future with a larger sample size.  
The time interval between death and autopsy for samples stored since 2016 and 2018 were 3 –
5 days and 1 – 9 days, respectively (Appendix A.5.). There was no clear indication that the 
variation in this time interval affected the DNA concentration or quality. Certain samples with 
1- and 2- day intervals had the highest DIN values and DNA concentrations, while other 
samples with 2-day intervals had poor DIN readings and low DNA concentrations. The only 
sample with a 9-day interval had a relatively high DIN value and DNA concentration as 
compared to samples with a 1-day interval. Therefore, it is unlikely that the difference in time 
interval had much of an effect on the DNA quality or quantity reported in this study.  
It was hypothesised by Reid et al. (2019) that the combination of a number of post-mortem 
variables, such as the time between death to specimen collection and death scene environmental 
factors, have a collaborative effect on DNA integrity (Reid, Martin & Heathfield, 2019). The 
majority of FFPETs used in this study were collected from cases where the deceased was 
exposed to an indoor environment at death. By virtue of being enclosed structures, indoor 
scenes typically offer more protection against these environmental factors (Reid, Martin & 
Heathfield, 2019). Due to the lack of variability in the samples in this study, there was 
insufficient data to identify the effect of environmental conditions on DNA integrity. A larger 




4.4. ETHICAL, LEGAL & LOGISTIC CONSIDERATIONS 
Despite its success and range of applications in demonstrated research, molecular autopsies are 
not currently performed as part of forensic post-mortem investigations in South Africa. Several 
legal, ethical and logistical issues need to be considered before molecular autopsies can be 
performed or can become routine in a medico-legal setting in South Africa. The use of genetic 
material in itself poses many ethical concerns regarding consent, confidentiality and reporting 
of the results. These concerns are then further complicated when considering genetic testing on 
deceased individuals who by their nature are not able to provide consent. Thus, the onus may 
fall on the next-of-kin to make decisions on behalf of the deceased (McGuire et al., 2014; Moore 
et al, 2016,). However, it can be argued that in order to prevent the relatives of the deceased 
from obstructing the progress of a forensic investigation, that consent should not be required 
for post-mortem genetic testing (de Vaal, 2018). Ultimately, a balance needs to be found so as 
to not violate the family’s expectation of control over the handling of the deceased while still 
allowing the forensic investigation to proceed without any hindrances (McGuire et al., 2014). 
The concept of informed consent and confidentiality may further be complicated by the fact 
that DNA is inherently familial and results from the molecular autopsy may reveal hereditary 
diseases that could affect the family members of the deceased. This poses questions as to 
whether the results from the molecular autopsy should be revealed to those family members 
and whether they should receive genetic counselling regarding their susceptibility to the 
hereditary condition (McGuire et al., 2014; Moore et al, 2016). While there are currently no 
regulations which govern these decisions, careful consideration must be taken in order to 
perform these investigations in an ethical manner. On one hand, there is justification in the 
favour of public health to perform genetic testing on at-risk individuals, however, in-depth 
discussions need to be had surrounding the potentially negative emotional impact it may have 
on family members of the deceased (McGuire et al., 2014; Moore et al, 2016, Heathfield, et al., 
2017). 
Furthermore, there are concerns regarding the use of genetic testing in sensitive cases such as 
infant deaths or suicides (Heathfield, et al., 2017; Clarke, A. & Wallgren-Pettersson, C., 2018). 
Despite evidence that a genetic predisposition can be determined for these cases, there is 
concern in attributing a disease or genetic disposition when the penetrance is not well 
understood. The mere presence of gene or genetic mutation does not automatically indicate the 




Hence, results from a molecular autopsy would merely indicate the probability of an individual 
exhibiting a particular trait or disease. In certain illnesses, the gene is always or very highly 
associated with the expression of a particular trait. However, in other instances, the gene is 
either lowly expressed or the expression probability is not known (Heathfield, et al., 2017; 
Clarke, A. & Wallgren-Pettersson, C., 2018). This again emphasises the need for specialist 
interpretation of results as misinterpretation can render the results would have little to no value. 
4.5. LIMITATIONS 
The strict selection criteria and the unavailability of FFPETs from certain ongoing forensic 
cases seemed to limit the sample size for this study. In future, it would be valuable to increase 
the sample size to reduce the possibility of type II error and strengthen the statistical 
significance of the results. A larger sample size would further allow for assessment of the 
biological relevance of results observed, such as the inverse correlation between time and 
A260/A230 ratios. This would provide a clearer understanding of the implications of various 
factors on DNA recovery.    
There was little variability in the sample set with regards to the pre-analytical conditions such 
as age, sex and post-mortem time and environmental conditions. The absence of this 
information in the case files may have contributed to the lack of variability in the samples. The 
clinical history and family pedigrees, pathological data from the post-mortem and ancillary 
investigations and case context are all critical information for assessing the eligibility of a case 
for molecular autopsy (Semsarian, Ingles & Wilde, 2015; Cunningham, 2017). Therefore, the 
lack of information further complicates the ability to perform molecular autopsy investigations.  
4.6. CONCLUSION  
The combination of tissue screening by microscopy and the optimisation of DNA extraction by 
adjusting the sectioning parameters introduced here was a simple and effective method for 
improving DNA recovery.   
Microscopic quantification of total nucleic acid content greatly improved the ability to identify 
FFPET blocks suitable for downstream DNA analyses. This was particularly useful for samples 
with little to no nucleic acid content. In these instances, microscopic quantification allowed for 




The sectioning parameters, namely, thickness and number of FFPET sections, were important 
factors in improving DNA recovery. Finer tissue sectioning enhanced the DNA concentration, 
purity and success of PCR-amplification of high MW fragments. Through the combination of 
finer tissue sectioning and an increased number of tissue sections, this study contributed to 
improving the DNA extraction method at for FFPET samples at SRM that had been stored for 
up to three years. This data provided insight into the quality and quantity of DNA we can gain 
from this method and insight into the eligibility for downstream molecular assays, such as NGS 
analysis. An improvement in the quality and quantity of DNA extracted from FFEPTs may have 
major implications in the investigation into unresolved SUDY cases by enhancing the ability to 
perform molecular autopsies for cause of death determination. 
In addition to the quantitative criteria for performing molecular autopsies, thorough discussions 
into the ethical, legal and logistic aspects would be required before molecular autopsies can be 
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A.1. JOURNAL ARTICLES INCLUDED IN LITERATURE REVIEW  
Table A.1.1. Chronological literature review of studies aimed at optimising DNA extraction to improve DNA recovery from FFPET. The variables under investigation in each 
study are indicated with symbols, □: tissue sampling; ○: tissue preparation; ▲: tissue digestion and ■: purification method. The DNA extraction kit used was indicated as follows: 
1: QIAamp® DNA Minikit (Qiagen); 2: HighPure DNA Preparation kit (Roche Life Science); 3: Ultraclean® Bloodspin® kit (Mo Bio Laboratories); 4: QIAamp® DNA Micro kit (Qiagen); 5: DNeasy Tissue kit (Qiagen); 
6: NucleoSpin® Tissue kit (Macherey Nagel); 7: EasyMAG nucliSens (bioMérieux); 8: Gentra column-kit (Qiagen); 9: GenElute® Mammalian Genomic DNA Miniprep Kit (Sigma-Aldrich); 10: TRI-Reagent® solution-
DNA (Sigma-Aldrich); 11: RecoverAll™ Total Nucleic Acid Isolation Kit (Thermo Fisher Scientific); 12: QIAamp DNA FFPE tissue kit (Qiagen); 13: AllPrep® DNA/RNA Mini Kit (Qiagen); 14: AllPrep® FFPE 
DNA/RNA Mini Kit (Qiagen); 15: Maxwell® 16 FFPE Tissue LEV DNA kit (Promega); 16: FFPE DNA extraction kit (Norgen Biotek); 17: Waxfree DNA kit (Trimgen); 18: RecoverAll DNA kit (Thermo Fisher 
Scientific); 19: Blood and Tissue kit (Qiagen); 20: Pinpoint Slide DNA Isolation System™ 20 (Zymo Research); 21: MasterPure™ DNA Purification Kit (Lucigen); 22: ZR FFPE DNA MiniPrep™ (Zymo Research); 23: 






Tissue sampling (□) Tissue preparation (○) Tissue digestion (▲) 
Purification 
method (■) 
Effect on DNA quality and quantity 
Scrape Core Section  Xylene 
Organic
solvent 













                




 Chelex-100 was the most successful compared to simple 
boiling and PCI for heat-deparaffinisation. 
 Thermal cycling was most successful compared to 
microwaving and xylene. 
 The kit had similar success (60%) to the Chelex-100 + 




                   
○ ▲ 
DNA concentration 
 Higher temperatures improved yield (dependent on pH). 
Purity 
 Quality ratios were highest for 120℃-heated samples. 
PCR success 









              




 PCR efficiency (90-386 bp) was 3-8X more for heated 
than unheated samples. 




                
▲ ○ 
DNA concentration 
 Higher temperatures had higher DNA yields. 
PCR success 
 Higher temperatures (100-120℃) improved PCR success 





                




 Heated samples had the highest DNA yield (160-211 µg)  
 The PCI method had the lowest DNA yield of 9 µg – 13 
µg 
Purity 
 NanoDrop™ quality ratios for heated samples were 
sufficient for qPCR, but the modified QiaAmp method 
had the best quality ratios. 
PCR success 
 100 % success for heat-treated samples (105 bp and 245 





                 
   
4 
○ ▲ ■ 
DNA concentration 
 Deparaffinisation (xylene vs pentane) had no effect on 
DNA quantity  
 Increasing temperature of digestion incubation has no 
effect on DNA yield 
PCR success 
 Deparaffinisation had no effect on PCR success 
 48 hour tissue digestion had an 8X increased PCR 
success than 24 hours 
 Increased temperatures (65℃ vs 55℃) increase the 
PCR success, but not in all cases – highly variable 










                 
□ 
PCR success 
 PCR success was greater for DNA from microtome 
sections (96%) vs scraping (93.75%) – result not 




    - - - -        





 In-house methods had higher yields than kits. 
Purity 
 In-house methods had the higher levels of RNA and 
protein contamination than the kits. 
PCR success 
 Differences in quality measurements did not affect the 
PCR success.  
2010 
(Huijsma
ns et al., 
2010) 
               





 QIAamp kit had the highest yield 
PCR success 
 Inhibition in Gentra kit and in-house heat treatment 
 100% success rate for all extraction methods except 
Gentra kit (400 bp) 
 75% success rate for QIAamp and EasyMAG kits and 
100% success rate for heat-treatment, but with low 





                 






 Extremely low DNA yield (0.17 ng/µl) in TRD kit 
compared to GEN (2,42 ng/µl) and RAD (4,17 ng/µl) 
kits and in-house PCE (5,47 ng/µl). However, there 
was great variability in across the samples. 
 Longer incubation times led to an increase in DNA 
yield 
PCR success 
 Most PCR inhibition with WXF kit 











                  
   
1
2 
□ ○ ■ 
DNA concentration 
 181% increased yield for PCI compared to QIAamp 
kit – increase of 1.7X (cores) and 1.9X (sections). 
 Significantly higher DNA yield per tissue volume for 
cores compared to sections. 
Purity 
 Larger fragments extracted with QIAamp than PCI. 




hi et al., 
2012) 
               




 Significantly greater yield for PCE than for kit and 
salting out methods for up to 5 years (liver, spleen and 
brain) 
Purity 
 PCE had lower purity than the kit and salting out 
methods 
 Salting out contained the most impurities 
 Brain>liver>spleen 
PCR success 
 Recent samples showed higher intensities on an 
agarose gel than those stored for 1 and 5 years 





            






 QIAamp FFPE kit yielded significantly more DNA 
than the other 2 kits 
Purity 
 All kits yielded pure DNA 
PCR success 
 100% success rate for all kits for 268 bp fragment 
 Maxwell kit had the highest and most consistent 
success for 402 bp fragment 
 Poor success for all kits for 618 bp fragment - AllPrep 










               





 PCI had the highest DNA yield – but with high levels of 
variation between replicates 
DNA degradation 
 Archival tissue showed high levels of fragmentation, 
which was not seen in recently prepared FFPET 
Purity 
 Highest purity obtained with PCI and QIAamp kit 
PCR success 




ili et al., 
2012) 
                






 Waxfree kit had the greatest yield followed by 
QIAamp, in-house PCI and RecoverAll kit 
DNA degradation 
Purity 
 Waxfree kit had the lowest purity 
PCR success 





              





 Greatest yields achieved with the QIAamp FFPE DNA 
kit compared to the mini kit and in-house CTAB 
methods 
DNA degradation 




               




 Genomic DNA extracted for ~67% cases using 
QIAamp – none for lab-based 
PCR success 
 76% success rate for the kit compared to 33% for the 










              
   
 19 
DNA concentration: 
 Linear increase in DNA concentration as the number 
of tissue sections increased when pressure cooked for 
between 5 and 30 mins 
 There was no significant difference in quantity when 
proK was added 
Purity 
 Better A260/A280 quality ratios for pressure cooking 
as compared to xylene deparaffinisation  
PCR success 
 100% Successful amplification of 193 bp fragments 
for FFPET stored between 0.2 – 20 years 
 21 % success for amplification of 546 bp for tissues 




               





 No significant difference when using different 
sampling methods 
 QIAamp had a 4.6X increased yield compared to 
Zymo column extraction kit 
 Longer proK digestion had no effect on yield 
Purity 





              
   
2
1  
DNA concentration & Purity: 


















                





 16 % increased success with using heat as compared 
to xylene 
 Less PCR inhibition when using heat (2 %) as 
compared to xylene (18 %) 
2017 
(Atanesy
an et al., 
2017) 
                 







 Highest yield with the in-house method followed by 
the QIAamp, Waxfree, Zymo research & RecoverAll 
Total Nucleic Acid kits 
Purity 
 All kits had pure DNA 






                





 Higher yield with less variability in commercial kits 
compared to in-house methods 
DNA degradation 
 DNA from all kits were highly degraded 
Purity 
 Roche kit had the highest PCR inhibitors and the in-
house method had the least  
PCR success 
 For 217 bp fragments, QIAgen had the lowest success 







Table A.1.1. (continued).  
2017 
(Watana
be et al., 
2017) 
              





 Yield between 2.5 - 10X higher for Waxfree method 
as compared to QIAamp  
 QIAamp had a higher yield for fragments between 129 
- 305 bp than the Waxfree 
 No difference for samples stored up to 12 years 
DNA degradation 
 Waxfree DNA was more fragmented than the QIAamp  
 Age-dependant DNA fragmentation - decrease 
between 0.5-3 years and 9-12 years 
Purity 
 Purity was higher for QIAamp than the Waxfree 





            






 Roche and Allprep kits had similar yields to QIAamp  
Purity 






            







 truXTRAC kit had the highest yield, but the most 
variation  
 there was no difference in yield when comparing the 
three Qiagen kits 
DNA degradation 
 truXTRAC kit had the highest DIN values 
 There was no difference between truXTRAC kit and 
QIAamp DIN.  
 Lowest integrity was given for the GeneRead kit 
PCR success 
 truXTRAC kit had better amplificability  
 Total 8 2 21 15 9 8 2 8 20 5 17 24 28 
59 




A.3. SUD CASE ADMITTANCE
Table A. 3. 1. Total SUD and SUDY cases admitted to Salt River mortuary between 2014 and 2018. 
Year Number of cases Number of SUD cases Number of SUDY cases 
2014 3461 590 138 
2015 3692 627 172 
2016 3657 727 203 
2017 3885 1106 334 
2018 4043 1107 321 
Total 11585 2940 1168 
Average 3747.6 831.4 233.6 
Table A. 3. 2. Categorisation of cause of death for SUDY cases as determined by post-mortem 
investigation and the number of cases where histology specimens were taken at Salt River mortuary 
between 2014 and 2018. 
Year 
Natural Unnatural Undetermined 
No histology Histology No histology Histology No histology Histology 
2018 215 54 14 6 92 79 
2017 250 44 13 2 67 52 
2016 124 26 8 1 70 58 
2015 124 24 8 0 40 30 
2014 93 22 5 1 36 17 
Total 806 170 48 10 305 236 





A.4. H&E STAINING PROTOCOL 
 
Following heat fixation of tissue sections to a glass slide, proceed to H&E staining as follows 
Rehydration  
1. Immerse the slide in xylene for 5 minutes 
2. Dip slide in 100 % ethanol ten times 
3. Slowly dip the slide in 96 % ethanol ten times 
4. Immerse the slide in 70 % ethanol supplemented with 3 % ammonium for 30 minutes 
Staining  
5. Dip the slide in 1 % acetic acid 6 times 
6. Wash the excess acetic acid off in a tap water bath for 5 minutes 
7. Immerse in Haematoxylin for 10 minutes 
8. Wash off the excess Haematoxylin in a tap water bath for 1 minute 
9. Blue in Scott’s water for 1 minute 
10. Immerse in Eosin-phloxine for 5 minutes 
11. Briefly rinse of excess Eosin in a tap water bath  
Dehydration  
12. Dip in 70 % ethanol 3 times 
13. Dip in 90 % ethanol 3 times 
14. Dip in 100 % ethanol 10 times (repeat this step twice more in fresh ethanol) 
15. Clear in xylol by dipping 10 times (repeat this step twice more in fresh xylol) 













A.5. CASE REVIEW DATA FOR SAMPLES  
Table A. 5. 1. Database of pre-analytical variables collected from the Office Autopsy Database at Salt 
River Mortuary for cases included in the control and test samples. Tissue types were selected based on 



















Reported cause of 
death 
Control 1 2018/04/30 2018/04/25 5 M 39 African Lung/brain Inside Liver pathology 




Control 3 2018/02/12 2018/02/08 4 M 23 African Lung/brain Unspecified Heat stroke 
Test 1 2016/12/07 2016/12/03 4 F 16 African Lung Inside Under investigation 
Test 2 2016/12/06 2016/12/02 4 F 30 coloured Kidney Inside Under investigation 
Test 3 2016/12/01 2016/11/28 3 F 23 African Brain Inside Under investigation 
Test 4 2016/10/26 2016/10/21 5 M 16 African Kidney Inside Under investigation 
Test 5 2016/10/21 2016/10/20 1 F 14 African Kidney Inside Under investigation 
Test 6 2016/10/13 2016/10/11 2 M 37 African Brain Inside Under investigation 
Test 7 2016/10/07 2016/09/28 9 M 39 coloured Kidney Unspecified Under investigation 
Test 8 2016/03/08 2016/03/05 3 M 21 African Kidney Outside Under investigation 
Test 9 2016/02/16 2016/02/14 2 F 33 African Brain Inside Under investigation 
Test 10 2016/01/26 2016/01/24 2 F 40 coloured Liver Inside Under investigation 
Test 11 2016/01/19 2016/01/15 4 F 18 African Brain Inside Under investigation 













A.6. DNA RECOVERY  
Table A. 6. 1. The median DNA recovery for FFPET sections of varying thickness. 5-µm and 3-µm 
samples were paired (n=3) for optimisation. Yield was quantified by qPCR amplification of the (S) small 




































5 62300 0.1083 0.0010 5.42 0.05 0.34 1.35 4.3 
10 62300 0.32 0.01 16.08 0.5 0.61 1.24 3.9 
All 62300 0.2150 0.0042 10.75 0.21 0.48 1.29 4.2 
3 
5 62300 0.63 0.01 31.30 0.5 0.58 1.46 3.8 
10 62300 0.8978 0.0135 44.89 0.68 1.11 1.62 2.1 
All 62300 0.6580 0.0091 32.91 0.46 0.69 1.46 2.5 
1 
30 56700 5.06 0.1479 253 7.395 2.32 1.88 1.8 
50 56700 4.821 0.1717 241 8.585 1.73 1.87 1.8 
100 86067 17.90 0.4363 895 21.82 1.52 1.83 1.7 






















































































































































Figure A. 7. 1. Distribution of fragment lengths for DNA extracted from FFPETs of varying thickness 
as quantified by the TapeStation System with the Genomic DNA ScreenTape® assay for highly degraded 

























Figure A. 7. 2. Digital capillary electrophoresis of DNA extracted from FFPET stored for 1-3 years using 
the 4200 TapeStation System with the Genomic DNA ScreenTape® assay. Samples are listed in 
chronological order as follows: 
Lane L: D1000 molecular weight marker (ladder).  
Lanes 1-11: test samples stored for between 2 and 3 years.  
Lanes 12-17: control samples stored for between 1 and 2 years.  
 
